Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherence

European Journal of Clinical Pharmacology

Volumn 69, Issue 12, 2013, Pages 2095-2101

  Poluzzi, Elisabetta ^a   Piccinni, Carlo ^a   Sangiorgi, Elisa ^b   Clo, Massimo ^b   Tarricone, Ilaria ^a   Menchetti, Marco ^a   De Ponti, Fabrizio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Drug Policy Service   (Italy)

Author keywords

Adherence; Antidepressant; Drug utilization; Prescription database

Indexed keywords

CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DRUG USE; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PREDICTION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RISK; TREATMENT DURATION; TREND STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; DRUG UTILIZATION; FEMALE; HUMANS; ITALY; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEUROTRANSMITTER UPTAKE INHIBITORS; YOUNG ADULT;

EID: 84892364572     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-013-1567-8     Document Type: Article

References (46)

1. Ilyas S, Moncrieff J (2012) Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. Br J Psychiatry 200(5):393-398
2. Parabiaghi A, Franchi C, Tettamanti M, Barbato A, D'Avanzo B, Fortino I, Bortolotti A, Merlino L, Nobili A (2011) Antidepressants utilization among elderly in Lombardy from 2000 to 2007: dispensing trends and appropriateness. Eur J Clin Pharmacol 67(10):1077-1083
3. Mojtabai R, Olfson M (2011) Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Health Aff (Millwood) 30(8):1434-1442
4. Arias LH, Lobato CT, Ortega S, Velasco A, Carvajal A, del Pozo JG (2010) Trends in the consumption of antidepressants in Castilla y Leon (Spain). Association between suicide rates and antidepressant drug consumption. Pharmacoepidemiol Drug Saf 19(9):895-900
5. Zahl PH, De LD, Ekeberg O, Hjelmeland H, Dieserud G (2010) The relationship between sales of SSRI, TCA and suicide rates in the Nordic countries. BMC Psychiatry 10:62. doi:10.1186/1471-244X-10-62.:62-10
6. L'uso dei farmaci in Italia-Rapporto Nazionale anno 2011, August, 2012. http://www.agenziafarmaco.gov.it/it/content/luso-dei-farmaciitalia-rapporto- osmed-2011 Accessed April 16, 2013
7. Kessler RC, Walters EE (1998) Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress Anxiety 7(1):3-14
8. Ormel J, Koeter MW, van den Brink W, van de Willige G (1991) Recognition, management, and course of anxiety and depression in general practice. Arch Gen Psychiatry 48(8):700-706
9. Ustun TB, Von Korff M (1995) Primary mental health services: access and provision of care. In: Ustun TB, Sartorius N (eds) Mental illness in general health care: an international study. Wiley, Chichester, UK, pp 347-360
10. Mercier A, Auger-Aubin I, Lebeau JP, Schuers M, Boulet P, Hermil JL, Van RP, Peremans L (2013) Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews. BMC Fam Pract 14:55. doi:10.1186/1471-2296-14-55.:55-14
11. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5(2):e45
12. Barbui C, Cipriani A, Patel V, Ayuso-Mateos JL, van Ommeren M (2011) Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry 198(1):11-16, sup
13. Trifiro G, Tillati S, Spina E, Ferrajolo C, Alacqua M, Aguglia E, Rizzi L, Caputi AP, Cricelli C, Samani F (2013) A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. Eur J Clin Pharmacol 69(2):227-236
14. Poluzzi E, Motola D, Silvani C, De Ponti F, Vaccheri A, Montanaro N (2004) Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement. Eur J Clin Pharmacol 59(11):825-831
15. Damiani G, Federico B, Silvestrini G, Bianchi CB, Anselmi A, Iodice L, Ronconi A, Navarra P, Da CR, Raschetti R, Ricciardi W (2013) Impact of regional copayment policy on selective serotonin reuptake inhibitor (SSRI) consumption and expenditure in Italy. Eur J Clin Pharmacol 69(4):957-963
16. NICE National Institute for Health and Clinical Excellence (2009) Depression: the treatment and management of depression in adults (update). http://guidance.nice.org.uk/CG90 Accessed February 21, 2013
17. Keller MB, Boland RJ (1998) Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. Biol Psychiatry 44(5):348-360
18. McLaughlin KA (2011) The public health impact of major depression: a call for interdisciplinary prevention efforts. Prev Sci 12(4):361-371
19. The Anatomical Therapeutic Chemical (ATC) classification system and the Defined Daily Dose (DDD) Index 2013, January 18, 2013. http://www.whocc.no/ Accessed April 16, 2013
20. Wichniak A, Wierzbicka A, Jernajczyk W (2012) Sleep and antidepressant treatment. Curr Pharm Des 18(36):5802-5817
21. Fagiolini A, Comandini A, Catena DM, Kasper S (2012) Rediscovering trazodone for the treatment of major depressive disorder. CNS Drugs 26(12):1033-1049
22. Wettermark B, Vlahovic-Palcevski V, Salvesen Blix H, Rønning M, Vander Stichele R (2008) Drug utilization research. In: Hartzema AG, Tilson HH, Chan KA (eds) Pharmacoepidemiology and therapeutic risk assessment. Harwey Whitney, Cincinnati, USA, pp 159-195
23. Von KM, Wagner EH, Saunders K (1992) A chronic disease score from automated pharmacy data. J Clin Epidemiol 45(2):197-203
24. Rosholm JU, Andersen M, Gram LF (2001) Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database study. Eur J Clin Pharmacol 56(12):923-929
25. Health at a Glance 2011-OECD Indicators, November 23, 2011. 10.1787/health-glance-2011-en Accessed April 16, 2013
26. Aguglia E, Ravasio R, Simonetti M, Pecchioli S, Mazzoleni F (2012) Use and treatment modalities for SSRI and SNRI antidepressants in Italy during the period 2003-2009. Curr Med Res Opin 28(9):1475-1484
27. Hernandez JF, Mantel-Teeuwisse AK, van Thiel GJ, Belitser SV, Warmerdam J, de Valk V, Raaijmakers JA, Pieters T (2012) A 10-year analysis of the effects of media coverage of regulatory warnings on antidepressant use in The Netherlands and UK. PLoS One 7(9):e45515
28. Sansone RA, Sansone LA (2012) Antidepressant adherence: are patients taking their medications? Innov Clin Neurosci 9(5-6):41-46
29. Burton C, Anderson N, Wilde K, Simpson CR (2012) Factors associated with duration of new antidepressant treatment: analysis of a large primary care database. Br J Gen Pract 62(595):e104-e112
30. Lu CY, Roughead E (2012)New users of antidepressantmedications: first episode duration and predictors of discontinuation. Eur J Clin Pharmacol 68(1):65-71
31. Liu XC, Chen Y, Faries D, Miner C, Swindle R (2009) Impact of comorbidities on antidepressant initiation: duloxetine, venlafaxine, and escitalopram versus other SSRIs. 38th American College of Clinical Pharmacology Annual Meeting
32. Liu X, Chen Y, Faries DE (2011) Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder. Clinicoecon Outcomes Res 3:63-72. doi:10.2147/CEOR.S17846. Epub;%2011 Mar 15.:63-72
33. Esposito D, Wahl P, Daniel G, Stoto MA, Erder MH, Croghan TW (2009) Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States. Clin Ther 31(3):644-656
34. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373(9665):746-758
35. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L (2012) Industry sponsorship and research outcome. Cochrane Database Syst Rev 12, MR000033. doi:10.1002/14651858.MR000033.pub2.:MR000033
36. Tarricone I, Stivanello E, Ferrari S, Colombini N, Bolla E, Braca M, Giubbarelli C, Costantini C, Cazzamalli S, Mimmi S, Tedesco D, Menchetti M, Rigatelli M, Maso E, Balestrieri M, Vender S, Berardi D (2012) Migrant pathways to community mental health centres in Italy. Int J Soc Psychiatry 58(5):505-511
37. Clancy Z, Keith SW, Rabinowitz C, Ceccarelli M, Gagne JJ, Maio V (2013) Statins and colorectal cancer risk: a longitudinal study. Cancer Causes Control 24(4):777-782
38. Poluzzi E, Piccinni C, Carta P, Puccini A, Lanzoni M, Motola D, Vaccheri A, De Ponti F, Montanaro N (2011) Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study. Eur J Clin Pharmacol 67(4):407-414
39. Berardi D, Menchetti M, Cevenini N, Scaini S, Versari M, De RD (2005) Increased recognition of depression in primary care. Comparison between primary-care physician and ICD-10 diagnosis of depression. Psychother Psychosom 74(4):225-230
40. Rix S, Paykel ES, Lelliott P, Tylee A, Freeling P, Gask L, Hart D (1999) Impact of a national campaign on GP education: an evaluation of the Defeat Depression Campaign. Br J Gen Pract 49(439):99-102
41. Macdonald S, Maxwell M, Wilson P, Smith M, Whittaker W, Sutton M, Morrison J (2012) A powerful intervention: general practitioners'; use of sickness certification in depression. BMC Fam Pract 13:82. doi:10.1186/1471- 2296-13-82.:82-13
42. Bortolotti B, Menchetti M, Bellini F, Montaguti MB, Berardi D (2008) Psychological interventions for major depression in primary care: a meta-analytic review of randomized controlled trials. Gen Hosp Psychiatry 30(4):293-302
43. Tarricone I, Stivanello E, Poggi F, Castorini V, Marseglia MV, Fantini MP, Berardi D (2012) Ethnic variation in the prevalence of depression and anxiety in primary care: a systematic review and metaanalysis. Psychiatry Res 195(3):91-106
44. Neumeyer-Gromen A, Lampert T, Stark K, Kallischnigg G (2004) Disease management programs for depression: a systematic review and meta-analysis of randomized controlled trials. Med Care 42(12):1211-1221
45. Andersson SJ, Troein M, Lindberg G (2005) General practitioners' conceptions about treatment of depression and factors that may influence their practice in this area. a postal survey. BMC Fam Pract 6(1):21
46. Andersson SJ, Troein M, Lindberg G (2001) Conceptions of depressive disorder and its treatment among 17 Swedish GPs. A qualitative interview study. Fam Pract 18(1):64-70